◆ FUNDING DATA
- Round
- Series B
- Amount
- $8.3M
- Location
- South San Francisco, United States
- Priority score
- 75/100
- Confidence
- 70/100
Investors
Savoir Capital · Catalio Capital Management · Humboldt Fund
Series B⬢ HOT
Spiral Therapeutics.
Spiral Therapeutics develops novel therapies for inner ear disorders using its Minimally Invasive Cochlear System (MICS™) for precise, sustained drug delivery to the cochlea, targeting conditions like hearing loss and balance disorders such as Meniere’s disease.